PRDS - Pardes Biosciences GAAP EPS of -$0.40 beats by $0.08 November, 07 2022 05:18 PM Pardes Biosciences Inc. Pardes Biosciences press release ( NASDAQ: PRDS ): Q3 GAAP EPS of -$0.40 beats by $0.08 . Pardes’ cash and cash equivalents as of September 30, 2022, were $209.1 million compared to $228.6 million as of June 30, 2022. For further details see: Pardes Biosciences GAAP EPS of -$0.40 beats by $0.08